Donate

tumor necrosis factor

Home»Posts tagged with»tumor necrosis factor

Janssen Biotech FDA approval Simponi Ulcerative Colitis

Janssen Biotech FDA approval Simponi Ulcerative Colitis Janssen Biotech has announced the FDA approval of Simponi (golimumab) to treat moderately to severely active ulcerative colitis (UC) in adult patients with corticosteroid dependence or an inadequate response to or failed to tolerate oral aminosalicylates, oral corticosteroids, azathioprine, or 6-mercaptopurine. The first and only subcutaneously administered anti-tumor […]

Avaxia cleared to start human trials of oral antibody for Crohns Disease

Avaxia cleared to start human trials of oral antibody for Crohn's disease …MedCity NewsA 7-year-old pharmaceutical company that's developed a new way to create and deliver an old kind of drug is making the critical transition to the clinical …

Ustekinumab Successful Refractory Crohn’s Disease

Ustekinumab success in refractory Crohn's diseaseNews-Medical.netBy Andrew Czyzewski, medwireNews Reporter. Patients with Crohn's disease who have failed to respond adequately to anti-tumor necrosis factor (anti-TNF) treatment may benefit from …

Researchers Suggest Biological Agent for Crohn’s Disease

TopNews United StatesResearchers Suggest a different Biological Agent for Crohn's Disease PatientsTopNews United StatesIf researchers' recent findings of a multicenter phase IIb trial are to be believed then a different biological agent type ca…

New Crohn’s Disease Treatment on the Horizon

Is a New Crohn's Disease Treatment on the Horizon?WebMD“About 60% of people with Crohn's disease will have an initial response to TNF drugs and of those, half will lose their response over the course of the year,” says researcher William J….

Crohn’s Disease Patients Refractory Tumor Necrosis

Crohn's Disease Patients Refractory To Tumor Necrosis Factor Inhibitors …The Herald | HeraldOnline.comCrohn's disease, a chronic autoimmune disorder of the gastrointestinal tract, affects an estimated 700,000 Americans,[1] and up to three-qua…

Pros and Cons of Combination Therapy for IBD

Gastroenterology & Endoscopy NewsPros and Cons of Combination Therapy for IBDGastroenterology & Endoscopy NewsShould patients with inflammatory bowel disease (IBD) receive combination therapy or monotherapy to treat their disease? Two experts debated b…

Phase 3 Study Results Show Anti-TNF SIMPONI® Active Ulcerative Colitis

Phase 3 Study Results Show Anti-TNF SIMPONI® Active Ulcerative Colitis

Phase 3 Study Results Show Anti-TNF SIMPONI® Induced Clinical Response in Adults With Moderately to Severely Active Ulcerative Colitis   First Presentation of Phase 3 Data Shows Significant Improvements in Clinical Remission, Mucosal Healing and Quality of Life Measures after SIMPONI Induction Treatment New study findings show that subcutaneous induction regimens of the anti-tumor necrosis […]

No Guts Know Glory

IDEAS Kids

IDEAS Kids

IBD Adventures